AMPA PROGRAM
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AMPA PROGRAM Trademark

Serial Number: 99278621

AMPA PROGRAM is a trademark filed by Neurocrine Biosciences, Inc. on July 11, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (229 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

July 11, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders

Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 24, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 24, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 25, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 17, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 11, 2025 MAFR
NEW APPLICATION ENTERED
Jul 11, 2025 NWAP